.Merck beats incomes assumptions, increases sales outlook on powerful requirement for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Forecasts as Keytruda Sales Growth BloombergMerck Stock: Pharma Titan Posts Powerful Results, But Expectation Falls Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats profit and purchases requirements among Keytruda strength, yet delivers combined full-year expectation MarketWatch.